Oct 30, 2023
There are several bone sarcoma types, originating from different cells within bone structure and require specialized diagnosis and treatment
Read More...
Oct 27, 2023
Future of gene therapies for hemophilia B treatment holds great promise, offering the potential for a paradigm shift in treatment approaches.
Read More...
Oct 25, 2023
Insulin Pens Market is generating huge demand due to rising prevalence of diabetes. Companies are developing innovative Insulin Pens.
Read More...
Oct 23, 2023
Following two prior rejections, FDA has granted long-awaited approval to Ardelyx's Xphozah for chronic kidney disease treatment in adults.
Read More...
Oct 20, 2023
On October 13 2023, the FDA has granted approval for Pfizer’s ulcerative colitis treatment, Etrasimod, under the brand name Velsipity.
Read More...
Oct 18, 2023
Allergies are on the rise globally, affecting millions of people and significantly impacting their quality of life. The ability to accurately diagnose and manage allergies is crucial for both patients and healthcare providers. With the rising prevalence of allergy, the demand for Allergy Diagnostics has increased m...
Read More...
Oct 16, 2023
Rare eye diseases can pose burden on patients. Top rare eye diseases are Stargardt Disease, Retinitis Pigmentosa, LHON, Retinoblastoma, LSCD
Read More...
Oct 11, 2023
Immunomodulators are reshaping the healthcare market outlook with their diverse benefits and applications, thereby improving health outcomes.
Read More...
Oct 09, 2023
FDA approved Rivfloza for primary hyperoxaluria treatment. This announcement comes as Novo continues to make strides in field of RNAi drugs.
Read More...
Oct 06, 2023
Since scopolamine transdermal patch FDA approval, no other treatments approved in US for nausea and vomiting induced by motion sickness.
Read More...
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Newsletter/Whitepaper